Literature DB >> 21276828

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

José L Moreno1, Terrell Holloway, Laura Albizu, Stuart C Sealfon, Javier González-Maeso.   

Abstract

Hallucinogenic drugs, including mescaline, psilocybin and lysergic acid diethylamide (LSD), act at serotonin 5-HT2A receptors (5-HT2ARs). Metabotropic glutamate receptor 2/3 (mGluR2/3) ligands show efficacy in modulating the responses induced by activation of 5-HT2ARs. The formation of a 5-HT2AR-mGluR2 complex suggests a functional interaction that affects the hallucinogen-regulated cellular signaling pathways. Here, we tested the cellular and behavioral effects of hallucinogenic 5-HT2AR agonists in mGluR2 knockout (mGluR2-KO) mice. Mice were intraperitoneally injected with the hallucinogens DOI (2 mg/kg) and LSD (0.24 mg/kg), or vehicle. Head-twitch behavioral response, expression of c-fos, which is induced by all 5-HT2AR agonists, and expression of egr-2, which is hallucinogen-specific, were determined in wild type and mGluR2-KO mice. [(3)H]Ketanserin binding displacement curves by DOI were performed in mouse frontal cortex membrane preparations. Head twitch behavior was abolished in mGluR2-KO mice. The high-affinity binding site of DOI was undetected in mGluR2-KO mice. The hallucinogen DOI induced c-fos in both wild type and mGluR2-KO mice. However, the induction of egr-2 by DOI was eliminated in mGlu2-KO mice. These findings suggest that the 5-HT2AR-mGluR2 complex is necessary for the neuropsychological responses induced by hallucinogens.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276828      PMCID: PMC3064746          DOI: 10.1016/j.neulet.2011.01.046

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  36 in total

Review 1.  Multiplicity of mechanisms of serotonin receptor signal transduction.

Authors:  J R Raymond; Y V Mukhin; A Gelasco; J Turner; G Collinsworth; T W Gettys; J S Grewal; M N Garnovskaya
Journal:  Pharmacol Ther       Date:  2001 Nov-Dec       Impact factor: 12.310

2.  Dopamine D2 receptor dimer formation: evidence from ligand binding.

Authors:  D Armstrong; P G Strange
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

Review 3.  On the fitting of binding data when receptor dimerization is suspected.

Authors:  J Giraldo
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

Review 4.  Agonist-trafficking and hallucinogens.

Authors:  Javier González-Maeso; Stuart C Sealfon
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 5.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

6.  Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration.

Authors:  Marie-Laure Rives; Claire Vol; Yugo Fukazawa; Norbert Tinel; Eric Trinquet; Mohammed Akli Ayoub; Ryuichi Shigemoto; Jean-Philippe Pin; Laurent Prézeau
Journal:  EMBO J       Date:  2009-07-09       Impact factor: 11.598

Review 7.  Group II metabotropic glutamate receptors and schizophrenia.

Authors:  José L Moreno; Stuart C Sealfon; Javier González-Maeso
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

Review 8.  Serotonin research: contributions to understanding psychoses.

Authors:  Mark A Geyer; Franz X Vollenweider
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

Review 9.  Psychedelics and schizophrenia.

Authors:  Javier González-Maeso; Stuart C Sealfon
Journal:  Trends Neurosci       Date:  2009-03-05       Impact factor: 13.837

Review 10.  Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices.

Authors:  George K Aghajanian
Journal:  Psychopharmacology (Berl)       Date:  2009-02-25       Impact factor: 4.530

View more
  76 in total

Review 1.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

Review 2.  Functional selectivity in GPCR heterocomplexes.

Authors:  J González-Maeso; S C Sealfon
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

3.  Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.

Authors:  José L Moreno; Patricia Miranda-Azpiazu; Aintzane García-Bea; Jason Younkin; Meng Cui; Alexey Kozlenkov; Ariel Ben-Ezra; Georgios Voloudakis; Amanda K Fakira; Lia Baki; Yongchao Ge; Anastasios Georgakopoulos; José A Morón; Graeme Milligan; Juan F López-Giménez; Nikolaos K Robakis; Diomedes E Logothetis; J Javier Meana; Javier González-Maeso
Journal:  Sci Signal       Date:  2016-01-12       Impact factor: 8.192

4.  Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Authors:  Luna Fomsgaard; Jose L Moreno; Mario de la Fuente Revenga; Tomasz Brudek; Dea Adamsen; Cristobal Rio-Alamos; Justin Saunders; Anders Bue Klein; Ignasi Oliveras; Toni Cañete; Gloria Blazquez; Adolf Tobeña; Albert Fernandez-Teruel; Javier Gonzalez-Maeso; Susana Aznar
Journal:  Mol Neurobiol       Date:  2017-03-06       Impact factor: 5.590

Review 5.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

Review 6.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

Review 7.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 8.  Lysergic acid diethylamide: a drug of 'use'?

Authors:  Saibal Das; Preeti Barnwal; Anand Ramasamy; Sumalya Sen; Somnath Mondal
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-23

9.  Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.

Authors:  Bruce E Blough; Antonio Landavazo; Ann M Decker; John S Partilla; Michael H Baumann; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

10.  Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.

Authors:  Theresa M Carbonaro; Matthew W Johnson; Ethan Hurwitz; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2017-11-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.